drug-naive type 2 diabetics with a screening hba1c of ≥ 7.5% and ≤ 10%

screening fpg ≥ 140 mg/dl and ≤ 220 mg/dl

bmi ≤ 40 kg/m2

active tuberculosis

symptoms of poorly controlled diabetes

history of diabetic ketoacidosis

significant cardiovascular history or gastrointestinal disorders

history of unstable or rapidly progressing renal disease

active liver disease and/or significant abnormal liver function

abnormal chest x-ray at screening indicative of tuberculosis or other infection